Agenus Inc. (AGEN) News
Track canonical SquawkNews coverage tagged to AGEN, Agenus Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
AGEN Agenus files to sell 2.13M shares of common stock for holders
AGEN Agenus files to sell 2.13M shares of common stock for holders
EQUITY | Jul 20, 2026, 10:54 AM UTC
H
Stock Market Today: Dow Jones Futures Fall, Nasdaq 100 Gains as Trump Calls US the 'Guardian' of Hormuz Strait—Tower Semiconductor, Twin Vee
U.S. stock futures were mixed on Tuesday, as the Nasdaq 100 index advanced, while the Dow Jones and S&P 500 indices fell, following Monday’s lower close. As the U.S. and Iran attacks continued for the third straight nigh
CENTRAL_BANK | Jul 14, 2026, 09:28 AM UTC
L
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
EQUITY | Jul 13, 2026, 04:19 PM UTC
L
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active L
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026
EQUITY | Jul 06, 2026, 11:30 AM UTC
M
AGEN Presents Survival Data
Agenus announces three-year survival data from Phase 1b BOT+BAL study in MSS metastatic colorectal cancer to be presented at ESMO GI 2026
EQUITY | Jun 25, 2026, 11:00 AM UTC